Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders

Yesterday, March 30, 2016, 46 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $34.31 to $30,062,500.00.

Highlighted Stocks Traded by Insiders:

SpartanNash (SPTN) - FREE Research Report

Brunot Edward L, who is Exec. V. P. and Pres. of MDV at SpartanNash, sold 2,722 shares at $28.58 on March 30, 2016. Following this transaction, the Exec. V. P. and Pres. of MDV owned 43,673 shares meaning that the stake was reduced by 5.87% with the 2,722-share transaction.

The shares most recently traded at $29.99, up $1.41, or 4.7% since the insider transaction. Historical insider transactions for SpartanNash go as follows:

  • 4-Week # shares sold: 65,417
  • 12-Week # shares sold: 65,417
  • 24-Week # shares sold: 65,417

The average volume for SpartanNash has been 223,300 shares per day over the past 30 days. SpartanNash has a market cap of $1.1 billion and is part of the services sector and wholesale industry. Shares are up 37.8% year-to-date as of the close of trading on Wednesday.

SpartanNash Company operates as a grocery distributor and retailer primarily in the United States. The company operates in three segments: Military, Food Distribution, and Retail. The stock currently has a dividend yield of 2.02%. The company has a P/E ratio of 17.8. Currently, there are no analysts who rate SpartanNash a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPTN - FREE

TheStreet Quant Ratings rates SpartanNash as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full SpartanNash Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Foot Locker (FL) - FREE Research Report

Gilbert Jarobin Jr, who is Director at Foot Locker, sold 5,000 shares at $65.77 on March 30, 2016. Following this transaction, the Director owned 11,668 shares meaning that the stake was reduced by 30% with the 5,000-share transaction.

The shares most recently traded at $65.19, down $0.58, or 0.89% since the insider transaction. Historical insider transactions for Foot Locker go as follows:

  • 4-Week # shares sold: 9,686
  • 12-Week # shares sold: 9,686
  • 24-Week # shares sold: 9,686

The average volume for Foot Locker has been 2.7 million shares per day over the past 30 days. Foot Locker has a market cap of $9.0 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 1% year-to-date as of the close of trading on Wednesday.

Foot Locker, Inc. operates as an athletic shoes and apparel retailer. The company operates in two segments, Athletic Stores and Direct-to-Customers. The stock currently has a dividend yield of 1.67%. The company has a P/E ratio of 17.1. Currently, there are 12 analysts who rate Foot Locker a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FL - FREE

TheStreet Quant Ratings rates Foot Locker as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Foot Locker Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cell Therapeutics (CTIC) - FREE Research Report

Bianco James A, who is President and CEO at Cell Therapeutics, sold 10,000 shares at $0.49 on March 30, 2016. Following this transaction, the President and CEO owned 1.8 million shares meaning that the stake was reduced by 0.55% with the 10,000-share transaction.

The shares most recently traded at $3.01, up $2.52, or 83.58% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares bought: 934,623
  • 4-Week # shares sold: 328,169
  • 12-Week # shares bought: 934,623
  • 12-Week # shares sold: 488,169
  • 24-Week # shares bought: 934,623
  • 24-Week # shares sold: 978,169

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Wavers, S&P 500 and Nasdaq Rise Ahead of Alphabet Earnings

Dow Wavers, S&P 500 and Nasdaq Rise Ahead of Alphabet Earnings

3 Simple Reasons to Buy Bank Stocks With Juicy Dividends

3 Simple Reasons to Buy Bank Stocks With Juicy Dividends

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads

PayPal's New Activist Investor Is Right for Thinking Stock Is 50% Undervalued

PayPal's New Activist Investor Is Right for Thinking Stock Is 50% Undervalued

Video: Jim Cramer on Financials, Industrials, Fiat Chrysler and Hasbro

Video: Jim Cramer on Financials, Industrials, Fiat Chrysler and Hasbro